tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Maneka Mirchandaney, 8 are a BUY (66.67%), 4 are a HOLD (33.33%).
Analyst Maneka Mirchandaney works with a stock forecast success ratio of 40% fulfilled within 84.4 days on average.
Maneka Mirchandaney’s has documented 24 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CRNX, Crinetics Pharmaceuticals at 11-Sep-2023.
Analyst best performing recommendations are on SGEN (SEAGEN).
The best stock recommendation documented was for SGEN (SEAGEN) at 5/17/2021. The price target of $153 was fulfilled within 3 days with a profit of $5.02 (3.39%) receiving and performance score of 11.31.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
80
$36.68 (84.67%)
60
1 months 1 days ago
6/10 (60%)
$33.19 (70.90%)
442
Buy
50
$6.68 (15.42%)
42
1 months 16 days ago
8/9 (88.89%)
$9.5 (23.46%)
435
Buy
54
$10.68 (24.65%)
48
1 months 16 days ago
3/4 (75%)
$13.5 (33.33%)
132
Buy
65
$21.68 (50.05%)
50
1 months 25 days ago
0/4 (0%)
$21.49 (49.39%)
Buy
52
$8.68 (20.04%)
45
2 months ago
3/4 (75%)
$11.06 (27.02%)
252
What Year was the first public recommendation made by Maneka Mirchandaney?
